Huabao International Holdings (336) H1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
H1 2026 earnings summary
2 Sep, 2026Executive summary
Revenue rose 15.9% year-over-year to RMB1.88 billion for the six months ended 30 June 2026, with strong growth in condiment (+29.9%), Huabao Technology (+20.4%), and aroma raw materials (+14.9%) segments, while tobacco raw materials declined 16.4% due to geopolitical factors.
Gross profit increased 8.8% to RMB766 million, but gross margin declined to 40.8% from 43.4% due to product mix and competition.
Operating profit rose 17.4% to RMB143 million; adjusted (Non-HKFRS) operating profit up 19.2% to RMB232 million, reflecting improved core profitability.
Net profit attributable to equity holders fell 11.7% to RMB104 million, mainly due to lower finance income and other gains.
Interim dividend of HK1.2 cents and special dividend of HK4.08 cents per share declared.
Financial highlights
Revenue: RMB1,878 million (+15.9% YoY); Gross profit: RMB766 million (+8.8% YoY); Gross margin: 40.8% (down 2.6pp YoY).
Operating profit: RMB143 million (+17.4% YoY); Operating margin: 7.6%.
Net profit: RMB124 million (+3.3% YoY); Net profit attributable to equity holders: RMB104 million (-11.7% YoY).
Adjusted EBITDA: RMB412 million (+12.5% YoY); Adjusted operating profit: RMB232 million (+19.2% YoY).
Basic and diluted EPS: RMB3.23 cents (vs. RMB3.66 cents YoY).
Outlook and guidance
Focus on internationalization, health industry, innovative tobacco, and high-potential customers.
Continued investment in R&D, digital transformation, and overseas capacity expansion.
Management expects to maintain growth momentum and enhance core competitiveness through technology-driven innovation and lean management.
Latest events from Huabao International Holdings
- Profit attributable to equity holders plunged 80.7% despite 3.0% revenue growth and mixed segment results.336
H1 2024 - Net loss from goodwill impairments despite revenue growth and improved liquidity.336
H2 2024 - Profit surged 298% year-over-year as revenue rose and prior-year impairments were absent.336
H1 2025 - Revenue up 3.3% YoY, operating loss narrowed, special dividend proposed amid global expansion.336
H2 2025